Optimization of the crystallizability of a single-chain antibody fragment

. 2014 Dec 01 ; 70 (Pt 12) : 1701-6. [epub] 20141114

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid25484230

Single-chain variable antibody fragments (scFvs) are molecules with immense therapeutic and diagnostic potential. Knowledge of their three-dimensional structure is important for understanding their antigen-binding mode as well as for protein-engineering approaches such as antibody humanization. A major obstacle to the crystallization of single-chain variable antibody fragments is their relatively poor homogeneity caused by spontaneous oligomerization. A new approach to optimization of the crystallizability of single-chain variable antibody fragments is demonstrated using a representative single-chain variable fragment derived from the anti-CD3 antibody MEM-57. A Thermofluor-based assay was utilized to screen for optimal conditions for antibody-fragment stability and homogeneity. Such an optimization of the protein storage buffer led to a significantly improved ability of the scFv MEM-57 to yield crystals.

Zobrazit více v PubMed

Arndt, K. M., Müller, K. M. & Plückthun, A. (1998). Biochemistry, 37, 12918–12926. PubMed

Atwell, J. L., Breheney, K. A., Lawrence, L. J., McCoy, A. J., Kortt, A. A. & Hudson, P. J. (1999). Protein Eng. 12, 597–604. PubMed

Bayly, A. M., Kortt, A. A., Hudson, P. J. & Power, B. E. (2002). J. Immunol. Methods, 262, 217–227. PubMed

Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S. M., Lee, T., Pope, S. H., Riordan, G. S. & Whitlow, M. (1988). Science, 242, 423–426. PubMed

Carmichael, J. A., Power, B. E., Garrett, T. P. J., Yazaki, P. J., Shively, J. E., Raubischek, A. A., Wu, A. M. & Hudson, P. J. (2003). J. Mol. Biol. 326, 341–351. PubMed

Chatenoud, L. (2003). Nature Rev. Immunol. 3, 123–132. PubMed

Dale, G. E., Oefner, C. & D’Arcy, A. (2003). J. Struct. Biol. 142, 88–97. PubMed

Ericsson, U. B., Hallberg, B. M., DeTitta, G. T., Dekker, N. & Nordlund, P. (2006). Anal. Biochem. 357, 289–298. PubMed

Goldstein, G. (1987). Transplant. Proc. 19, 1–6. PubMed

Griep, R. A., van Twisk, C., Kerschbaumer, R. J., Harper, K., Torrance, L., Himmler, G., van der Wolf, J. M. & Schots, A. (1999). Protein Expr. Purif. 16, 63–69. PubMed

Hilgert, I., Horejsi, V. & Kristofova, H. (1989). Czechoslovakia Patent 253 687.

Holliger, P., Prospero, T. & Winter, G. (1993). Proc. Natl Acad. Sci. USA, 90, 6444–6448. PubMed PMC

Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M.-S., Novotný, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., Crea, R. & Oppermann, H. (1988). Proc. Natl Acad. Sci. USA, 85, 5879–5883. PubMed PMC

Jäger, M. & Plückthun, A. (1999). FEBS Lett. 462, 307–312. PubMed

Kabat, E. A., Wu, T. T., Perry, H. M., Gottesman, K. S. & Foeller, C. (1991). Sequences of Proteins of Immunological Interest, 5th ed. Bethesda: National Institutes of Health.

Kaprálek, F., Jecmen, P., Sedlácek, J., Fábry, M. & Zadrazil, S. (1991). Biotechnol. Bioeng. 37, 71–79. PubMed

Kipriyanov, S. M., Moldenhauer, G. & Little, M. (1997). J. Immunol. Methods, 200, 69–77. PubMed

Kortt, A. A., Lah, M., Oddie, G. W., Gruen, C. L., Burns, J. E., Pearce, L. A., Atwell, J. L., McCoy, A. J., Howlett, G. J., Metzger, D. W., Webster, R. G. & Hudson, P. J. (1997). Protein Eng. 10, 423–433. PubMed

Kortt, A. A., Malby, R. L., Caldwell, J. B., Gruen, L. C., Ivancic, N., Lawrence, M. C., Howlett, G. J., Webster, R. G., Hudson, P. J. & Colman, P. M. (1994). FEBS J. 221, 151–157. PubMed

Kung, P., Goldstein, G., Reinherz, E. L. & Schlossman, S. F. (1979). Science, 206, 347–349. PubMed

Orlandi, R., Güssow, D. H., Jones, P. T. & Winter, G. (1989). Proc. Natl Acad. Sci. USA, 86, 3833–3837. PubMed PMC

Pan, Q., Brodeur, J. F., Drbal, K. & Dave, V. P. (2006). Mol. Immunol. 43, 1741–1750. PubMed

Pantoliano, M. W., Bird, R. E., Johnson, S., Asel, E. D., Dodd, S. W., Wood, J. F. & Hardman, K. D. (1991). Biochemistry, 30, 10117–10125. PubMed

Papanastasiou, D., Mamalaki, A., Eliopoulos, E., Poulas, K., Liolitsas, C. & Tzartos, S. J. (1999). J. Neuroimmunol. 94, 182–195. PubMed

Pisackova, J., Prochazkova, K., Fabry, M. & Rezacova, P. (2013). Cryst. Growth Des. 13, 844–848.

Power, B. E., Doughty, L., Shapira, D. R., Burns, J. E., Bayly, A. M., Caine, J. M., Liu, Z., Scott, A. M., Hudson, P. J. & Kortt, A. A. (2003). Protein Sci. 12, 734–747. PubMed PMC

Procházková, K., Čermáková, K., Pachl, P., Sieglová, I., Fábry, M., Otwinowski, Z. & Řezáčová, P. (2012). Acta Cryst. D68, 176–185. PubMed PMC

Reinhard, L., Mayerhofer, H., Geerlof, A., Mueller-Dieckmann, J. & Weiss, M. S. (2013). Acta Cryst. F69, 209–214. PubMed PMC

Rezacova, P., Brynda, J., Lescar, J., Fabry, M., Horejsi, M., Sieglova, I., Sedlacek, J. & Bentley, G. A. (2005). J. Struct. Biol. 149, 332–337. PubMed

Rezacova, P., Lescar, J., Brynda, J., Fabry, M., Horejsi, M., Sedlacek, J. & Bentley, G. A. (2001). Structure, 9, 887–895. PubMed

Sgro, C. (1995). Toxicology, 105, 23–29. PubMed

Weiss, A. (1990). J. Clin. Invest. 86, 1015–1022. PubMed PMC

Whitlow, M., Filpula, D., Rollence, M. L., Feng, S. L. & Wood, J. F. (1994). Protein Eng. 7, 1017–1026. PubMed

Wolf, E., Hofmeister, R., Kufer, P., Schlereth, B. & Baeuerle, P. A. (2005). Drug Discovery Today, 10, 1237–1244. PubMed

Zdanov, A., Li, Y., Bundle, D. R., Deng, S.-J., MacKenzie, C. R., Narang, S. A., Young, N. M. & Cygler, M. (1994). Proc. Natl Acad. Sci. USA, 91, 6423–6427. PubMed PMC

Zulauf, M. & D’Arcy, A. (1992). J. Cryst. Growth, 122, 102–106.

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace